Sequential Compression Device in Distributive Peripheral Edema and Hemodynamic Stability Among Pa… (NCT07305870) | Clinical Trial Compass
By InvitationNot Applicable
Sequential Compression Device in Distributive Peripheral Edema and Hemodynamic Stability Among Patients in Critical Care Units
Iraq56 participantsStarted 2025-12-28
Plain-language summary
Objectives of The Study:
1. Assess the effectiveness of sequential compression device on distributive peripheral edema and hemodynamic stability for patients in critical care units.
2. Find out relationships between the effectiveness of sequential compression device, range of motion, and synergic effectiveness of both interventions with patients' demographic characteristics.
Who can participate
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients who were hospitalized in critical care units.
* Subjects over the age of 18 years.
* Presence of peripheral edema (pitting edema ≥1+ in lower extremities).
* Patients how are hemodynamically stable.
* Patients how are able to tolerate positioning for interventions.
Exclusion Criteria:
* Patients with lymphedema.
* Patients with chronic kidney disease.
* patients with presence of deep vein thrombosis, severe peripheral arterial disease, or phlebitis.
* patients with open wounds, ulcers, or skin infections on lower limbs.
* patients with fractures, orthopedic surgery, or joint immobility in lower extremities.
* patients with severe cardiac failure or pulmonary edema.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Peripheral edema
Timeframe: The degree of edema will be measured before applying interventions and after 5 consecutive days if study
2
Hemodynamic Stability
Timeframe: Hemodynamic parameters will be measured before applying interventions and after 5 consecutive days if study